A new imaging agent, 68Ga-ABY-025, can predict early metabolic response to human epidermal growth factor receptor 2 (HER2)-targeted treatment in HER2-positive metastatic breast cancer patients, according to new research published ...
Sep 27, 2023
0
34
Breast cancer is a heterogeneous disease, but 70% of cases are characterized by the presence of hormone receptors for estrogen, progesterone, or both. The first line of treatment for these patients, when presenting with metastatic ...
Jul 13, 2023
0
1
Metastatic breast cancer can be a daunting diagnosis, but the prognosis has improved somewhat with advances in treatment.
Jun 26, 2023
0
9
A novel, automated liquid biopsy test in development by researchers at the Johns Hopkins Kimmel Cancer Center can be used to predict early disease progression and potential survival among patients with metastatic breast cancer ...
Jun 13, 2023
0
21
Even when the disease is caught early, breast cancer recurrence is relatively commonplace—and for survivors, the prospect can be daunting.
Jun 2, 2023
0
42
Breast cancer is resistant to immunotherapies; therefore, bioengineers and oncologists seek to develop a slew of therapeutic strategies to overcome this challenge. In a new report in Science Advances, Kerui Wu and colleagues ...
A new research paper titled "Genomic landscape of metastatic breast cancer (MBC) patients with methylthioadenosine phosphorylase (MTAP) loss" has been published in Oncotarget.
Mar 14, 2023
0
2
Scientists have discovered why breast cancer cells that have spread to the lungs may "wake up" following years of sleep, forming incurable secondary tumors.
Mar 13, 2023
0
150
Metastatic breast cancer has no cure and has proven stubbornly resistant to one of the most innovative and promising new cancer treatments: immunotherapy.
Mar 8, 2023
0
5
After six years of painful injections, Stephanie Walker has had enough.
Feb 8, 2023
0
4
